<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">469033681</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180323132750.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170328e19920801xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF00215657</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF00215657</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">T-cell receptor gamma/delta: comparison of gene configurations and function between humans and chimpanzees</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Els Sturm, Ronald Bontrop, Rea Vreugdenhil, Nel Otting, Reinder Bolhuis]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">The human and chimpanzee T-cell receptor gamma-delta (TCR γδ) bearing cells represent a minor subset (3-8%) of T lymphocytes. In the periphery, the TCR γδ population has a restricted combinatorial repertoire. The TCRD-V1 and-V2 gene products are expressed in a mutually exclusive fashion, whereas, the TCRD-V2 and the TCRG-V9 encoded proteins show, in general, a coordinated expression. Restriction fragment length polymorphism analysis showed conservation of the restriction sites that identify the TCRG-V9 and TCRD-V2 rearrangements. The human TCRG-V9 locus has two alleles, TCRG-V9A1 and TCRG-V9A2 differing at codon position 31. The chimpanzee TCRG-V9 gene product differs from the products of the human TCRG-V9A1 and TCRG-V9A2 allele by two and three amino acid replacements, respectively. The human and the chimpanzee TCRG-V9-TCRD-V2 lymphocytes show a similar specific proliferative and cytolytic response to human Daudi Burkitt's lymphoma cells. Therefore, the amino acid replacements found in the chimpanzee TCRG-V9 gene product do not change the superantigen specificity across this species barrier.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer-Verlag, 1992</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Sturm</subfield>
   <subfield code="D">Els</subfield>
   <subfield code="u">Department of Immunology, Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Bontrop</subfield>
   <subfield code="D">Ronald</subfield>
   <subfield code="u">ITRI/TNO, Rijswijk, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Vreugdenhil</subfield>
   <subfield code="D">Rea</subfield>
   <subfield code="u">Department of Immunology, Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Otting</subfield>
   <subfield code="D">Nel</subfield>
   <subfield code="u">ITRI/TNO, Rijswijk, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Bolhuis</subfield>
   <subfield code="D">Reinder</subfield>
   <subfield code="u">Department of Immunology, Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Immunogenetics</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">36/5(1992-08-01), 294-301</subfield>
   <subfield code="x">0093-7711</subfield>
   <subfield code="q">36:5&lt;294</subfield>
   <subfield code="1">1992</subfield>
   <subfield code="2">36</subfield>
   <subfield code="o">251</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF00215657</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF00215657</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Sturm</subfield>
   <subfield code="D">Els</subfield>
   <subfield code="u">Department of Immunology, Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Bontrop</subfield>
   <subfield code="D">Ronald</subfield>
   <subfield code="u">ITRI/TNO, Rijswijk, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Vreugdenhil</subfield>
   <subfield code="D">Rea</subfield>
   <subfield code="u">Department of Immunology, Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Otting</subfield>
   <subfield code="D">Nel</subfield>
   <subfield code="u">ITRI/TNO, Rijswijk, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Bolhuis</subfield>
   <subfield code="D">Reinder</subfield>
   <subfield code="u">Department of Immunology, Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Immunogenetics</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">36/5(1992-08-01), 294-301</subfield>
   <subfield code="x">0093-7711</subfield>
   <subfield code="q">36:5&lt;294</subfield>
   <subfield code="1">1992</subfield>
   <subfield code="2">36</subfield>
   <subfield code="o">251</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
